NCT05443971 2026-02-06
Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen
Mayo Clinic
Phase 1 Terminated
Mayo Clinic
Adaptimmune
Case Comprehensive Cancer Center
Emory University
M.D. Anderson Cancer Center
University of Kentucky
National Cancer Institute (NCI)
AstraZeneca